Press archive

Welcome to our Press Archive section below you will find Archive stories and posts and all types of information from the past. Please feel free to browse and enjoy.
  • All
  • Ad-hoc
  • Finance
  • Innovation
  • Leadership
  • Press
Bachem in Bubendorf Switzerland
02Jan2023

New Site Manager at Bachem Headquarters: Meet Frank Dettner
We are pleased to announce that Frank Dettner will take on the role of Site Manager in Bubendorf (Ba...
Large Volume Peptide Contract
16Dec2022

Bachem signs long-term follow-on contract for peptides
Contract signed with a total minimum order volume of CHF 1 billion over a five-year period from 2025...
Bachem GMP Site in Torrance
14Nov2022

Bachem Welcomes New Site Manager in Torrance: Luckner Ulysse
We are pleased to announce that Luckner Ulysse will take on the role of Site Manager in Torrance (US...
Sisslerfeld Header IMG2
05Oct2022

Bachem expands presence in northwestern Switzerland. New production site planned in Sisslerfeld.
The third Bachem site in Switzerland will be built in Sisslerfeld in the municipality of Eiken (cant...
News Peptide Related3
20Sep2022

Bachem signs large volume contracts for peptides
Two contracts signed with order volumes of CHF 25 million in 2023 and CHF 150 million in 2024....
CIO
09Sep2022

CHANGE TO THE IT LEADERSHIP
We are pleased to announce the appointment of a new Global CIO. ...
Bachem Headquarter Side Angle
05Aug2022

Addition to the Bachem leadership team
We are pleased to announce the appointment of a new Global Head of HR / Chief Human Resources Office...
Bachem into Industry 4.0
11Jul2022

Bachem’s Journey to Industry 4.0
Bachem has started its journey to industry 4.0 and has reached a new level of automation and digital...
Innovation Oligonucleotide Manufacturing
11May2022

Innovation transforming oligonucleotide manufacturing
Bachem set up unique, innovative equipment that optimizes capacity, delivers high-quality products a...
Annual General Meeting Bachem 2022
27Apr2022

Bachem Annual General Meeting 2022
The Annual General Meeting (AGM) 2022 has approved all proposals of the Board of Directors...
Oligonucleotide Synthesizer
26Apr2022

Entering strategic collaboration with Lilly to manufacture oligo-based drug substances
The annual order volume has the potential to achieve around CHF 100 million....

Contact us

  • Please choose if you would like to receive additional email communications from Bachem:

  • Fields marked with an asterisk (*) are required

  • Hidden
    :
  • Hidden
  • This field is for validation purposes and should be left unchanged.